Search Results - "Parkkola, A"

Contrasting microbiotas between Finnish and Estonian infants: Exposure to Acinetobacter may contribute to the allergy gap by Ruokolainen, Lasse, Parkkola, Anna, Karkman, Antti, Sinkko, Hanna, Peet, Aleksandr, Hämäläinen, Anu‐Maaria, Hertzen, Leena, Tillmann, Vallo, Koski, Katriina, Virtanen, Suvi M., Niemelä, Onni, Haahtela, Tari, Knip, Mikael

“…Background Allergic diseases are more common in Finland than in Estonia, which—according to the biodiversity hypothesis—could relate to differences in early…”
Get full text

Recruitment and retention of participants for an international type 1 diabetes prevention trial: A coordinators’ perspective by Suomalainen, Heli, Hyytinen, Mila, Salonen, Marja, Catte, Daniel, Läärä, E, Lernmark, Å, Schmidt, B, Knip, M, Koski, M, Salonen, M, Cuthbertson, D, Dupré, J, Fraser, W, Lawson, M, Mahon, JL, Taback, SP, Becker, D, Virtanen, SM, Catteau, J, Crock, P, Bere, L, Metzger, D, Kwan, J, Stephure, DK, Schwarz, W, Lawson, ML, Martin, M-J, Morin, V, Huot, C, Gonthier, M, Thibeault, M, Legault, L, Laforte, D, Cummings, EA, Houlden, R, Carson, G, Sankaran, K, Penner, M, White, RA, Robson, L, Al Taji, E, Mendlova, P, Vavrinec, J, Vosahlo, J, Venhacova, J, Gogelova, P, Einberg, Ü, Riikjärv, M-A, Kleemola, P, Parkkola, A, Järvenpää, A-L, Haavisto, H, Tenhola, S, Aspholm, S, Holm, C, Ylitalo, S, Lounamaa, R, Nuuja, A, Veijola, R, Tapanainen, P, Käär, M-L, Mustila, T, Virransalo, R, Aschemeier, B, Danne, T, Krikovszky, D, Madácsy, L, Pozzilli, P, Mannu, C, de Beaufort, C, Jarosz-Chobot, P, Cypryk, K, Zawodniak-Szalapska, M, Castano, L, Oyarzabal, M, Serrano-Ríos, M, Martínez-Larrad, MT, Hawkins, FG, Rodriguez Arnau, D, Ludvigsson, J, Smolinska Konefal, M, Fors, H, Nordwall, M, Edenwall, H, Gadient, M, Schoenle, E, Tanner-Blasiar, M, White, N, Rogers, L, Frazer, T, Torres, J, Goland, R, Nelson, M, Schachner, H, Softness, B, Ilonen, J, Trucco, M, Nichol, L, Savilahti, E, Vaarala, O

“…Background The Trial to Reduce Insulin Dependent Diabetes Mellitus in the Genetically at Risk (TRIGR) is the first multicenter international type 1 diabetes…”
Get full text